Literature DB >> 8627650

Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.

J Cao1, I W Park, A Cooper, J Sodroski.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of CD4-positive lymphocytes is accompanied by acute cytopathic effects, i.e., syncytium formation and single-cell lysis. Syncytium formation involves cell-cell fusion mediated by viral envelope glycoproteins on the surface of infected cells and by CD4 glycoproteins on adjacent cells. The molecular basis for the lysis of single-HIV-1 infected cells is unclear. Here we report that the expression of functional envelope glycoproteins from primary and laboratory-adapted HIV-1 isolates resulted in the lysis of single CD4-positive lymphocytes. As was previously observed in HIV-1 infected cultures, single-cell lysis in this system primarily involved necrosis and was not inhibited by soluble CD4. Binding of the viral envelope glycoproteins to the CD4 glycoprotein facilitated, but was not sufficient for, cytolysis. Importantly, the ability of the HIV-1 envelope glycoproteins to mediate membrane fusion was essential for single-cell killing. By contrast, the long cytoplasmic tail of the gp41 transmembrane envelope glycoprotein was neither necessary nor sufficient for single-cell lysis. These results suggest that intracellular envelope glycoprotein-CD4 interactions initiate autofusion events that disrupt cell membrane integrity, leading to single-cell lysis by HIV-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627650      PMCID: PMC189953     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Changes in the cytopathic effects of human immunodeficiency virus type 1 associated with a single amino acid alteration in the ectodomain of the gp41 transmembrane glycoprotein.

Authors:  J Cao; B Vasir; J G Sodroski
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

2.  Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.

Authors:  M A Miller; T A Mietzner; M W Cloyd; W G Robey; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

3.  Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.

Authors:  Y Tani; H Tian; H C Lane; D I Cohen
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

4.  Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals.

Authors:  S Patterson; M S Roberts; N R English; S E Macatonia; M N Gompels; A J Pinching; S C Knight
Journal:  Res Virol       Date:  1994 May-Aug

5.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.

Authors:  Y Koga; K Nakamura; M Sasaki; G Kimura; K Nomoto
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

7.  Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.

Authors:  X Yu; M F McLane; L Ratner; W O'Brien; R Collman; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes.

Authors:  L Chernomordik; A N Chanturiya; E Suss-Toby; E Nora; J Zimmerberg
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.

Authors:  E Kondo; T Yoshino; I Yamadori; Y Matsuo; N Kawasaki; J Minowada; T Akagi
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Programmed cell death and Bcl-2 protection in the absence of a nucleus.

Authors:  M D Jacobson; J F Burne; M C Raff
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

View more
  55 in total

1.  The Nef protein of HIV-1 associates with rafts and primes T cells for activation.

Authors:  J K Wang; E Kiyokawa; E Verdin; D Trono
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Authors:  B Etemad-Moghadam; D Rhone; T Steenbeke; Y Sun; J Manola; R Gelman; J W Fanton; P Racz; K Tenner-Racz; M K Axthelm; N L Letvin; J Sodroski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

Authors:  Mohan Somasundaran; Mark Sharkey; Beda Brichacek; Katherine Luzuriaga; Michael Emerman; John L Sullivan; Mario Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.

Authors:  Yael Wexler-Cohen; Avraham Ashkenazi; Mathias Viard; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2010-07-06       Impact factor: 5.191

5.  Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.

Authors:  Miranda Harris; Sneha Ratnapriya; Angela Chov; Héctor Cervera; Alisha Block; Christopher Gu; Nathaniel Talledge; Louis M Mansky; Joseph Sodroski; Alon Herschhorn
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

6.  High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo.

Authors:  B D Jamieson; C H Uittenbogaart; I Schmid; J A Zack
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.

Authors:  Navid Madani; Amy M Hubicki; Ana Luisa Perdigoto; Martin Springer; Joseph Sodroski
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

8.  Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin.

Authors:  H Ishikawa; M Sasaki; S Noda; Y Koga
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Early transcription from nonintegrated DNA in human immunodeficiency virus infection.

Authors:  Yuntao Wu; Jon W Marsh
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.

Authors:  Geoffrey H Holm; Chengsheng Zhang; Paul R Gorry; Keith Peden; Dominique Schols; Erik De Clercq; Dana Gabuzda
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.